Related Experiment Videos
[LP-X in the first month of life (author's transl)]
Insights
Lipoprotein-X (LP-X) is frequently detected in newborns, unlike in adults where it indicates cholestasis. This finding suggests LP-X may not be a specific marker for cholestasis in neonates.
Area of Science:
- Biochemistry
- Neonatology
- Clinical Diagnostics
Context:
- Cholestasis diagnosis in adults relies on detecting abnormal lipoprotein LP-X.
- The clinical significance of LP-X in neonates, particularly premature and newborn infants, remains unclear.
Purpose:
- To investigate the diagnostic specificity of LP-X for cholestasis in premature and newborn infants.
- To explore potential explanations for LP-X presence in neonatal sera.
- To assess LP-X's utility in differentiating obstructive jaundice in neonates.
Summary:
- LP-X was detected in 75% of 1056 sera samples from 270 neonates.
- This high prevalence contrasts with its specificity for cholestasis in adults.
- Three hypotheses are proposed for LP-X's appearance in newborns.
Impact:
- Challenges the use of LP-X as a universal cholestasis biomarker.
- Highlights the need for distinct diagnostic criteria in neonatal cholestasis.
- Suggests semi-quantitative LP-X analysis may aid neonatal jaundice diagnosis.
Abstract:
An abnormal lipoprotein can be detected in the sera of patients suffering from intra- and extrahepatic cholestasis. The specificity of LP-X detection for the diagnosis of cholestasis in adult persons was proved by extensive investigations. The aim of this study was to examine the specificity of LP-X with regard to cholestasis in the postnatal phase of premature and newborn infants. 1056 sera of 270 newborns were tested and in 75% of these cases LP-X was found to be positive. Three hypothetical explanations are given concerning the appearance of LP-X in the sera of premature and newborn infants. The semi-quantitative determination of LP-X also represents a possibility for differential diagnosis of obstructive jaundice in the neonatal period.